|
WO2021032777A1
|
|
Oligonucleotide conjugate compositions and methods of use
|
|
WO2021021713A1
|
|
Compositions and methods of using c/ebp alpha sarna
|
|
WO2020208361A1
|
|
Sirt1-sarna compositions and methods of use
|
|
CA3102334A1
|
|
Combination therapies comprising c/ebp alpha sarna
|
|
US2021102204A1
|
|
Sirt1-sarna compositions and methods of use
|
|
EP3752165A1
|
|
C/ebp alpha sarna compositions and methods of use
|
|
EP3679140A1
|
|
Stabilized cebpa sarna compositions and methods of use
|
|
EP3679139A1
|
|
Stabilized hnf4a sarna compositions and methods of use
|
|
WO2016170348A2
|
|
Sarna compositions and methods of use
|
|
US2020376020A1
|
|
C/EBP alpha saRNA compositions and methods of use
|
|
WO2015162422A1
|
|
Sarna compositions and methods of use
|
|
CN112220797A
|
|
C/EBP alpha compositions and methods of use
|
|
EP3456828A1
|
|
Albumin production and cell proliferation
|
|
CN103314108A
|
|
Short rna molecules
|
|
GB201103745D0
|
|
Cell induction
|
|
GB201016989D0
|
|
Cell induction
|
|
GB201016857D0
|
|
Culture method
|
|
GB201010557D0
|
|
RNA molecules and uses thereof
|
|
GB0903562D0
|
|
Double stranded RNA molecule comprising siRNA and miRNA precursors
|
